455 — Tianda Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual balance sheet for Tianda Pharmaceuticals, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	HKAS	HKAS	HKAS	HKAS	—
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	235	349	162	85.7	64.8
Net Total Accounts Receivable
Net Total Receivables	148	145	106	81.4	76.5
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	606	577	344	216	198
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	379	436	413	387	385
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,133	1,164	917	765	748
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	214	272	313	251	238
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	377	407	325	259	291
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	757	757	592	506	457
Total Liabilities & Shareholders' Equity	1,133	1,164	917	765	748
Total Common Shares Outstanding